These data collectively suggest that promoter hypermethylation of DAPK1 and RASSF-1α genes is probably an important reason for their down-regulation in gene level, and is presumably associated with BC development and progression, whereas it is currently unknown about which reasons cause the promoter hypermethylation in BC. This evidence concerns the gene DAPK1 and breast cancer.